BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27270502)

  • 1. Kif14 overexpression accelerates murine retinoblastoma development.
    O'Hare M; Shadmand M; Sulaiman RS; Sishtla K; Sakisaka T; Corson TW
    Int J Cancer; 2016 Oct; 139(8):1752-8. PubMed ID: 27270502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of KIF14 in retinoblastoma: association with older age at diagnosis.
    Madhavan J; Coral K; Mallikarjuna K; Corson TW; Amit N; Khetan V; George R; Biswas J; Gallie BL; Kumaramanickavel G
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4901-6. PubMed ID: 17962437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.
    Pajovic S; Corson TW; Spencer C; Dimaras H; Orlic-Milacic M; Marchong MN; To KH; Thériault B; Auspitz M; Gallie BL
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7618-24. PubMed ID: 21862643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association.
    Madhavan J; Mitra M; Mallikarjuna K; Pranav O; Srinivasan R; Nagpal A; Venkatesan P; Kumaramanickavel G
    Mol Vis; 2009; 15():235-40. PubMed ID: 19190782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography enables imaging of tumor initiation in the TAg-RB mouse model of retinoblastoma.
    Wenzel AA; O'Hare MN; Shadmand M; Corson TW
    Mol Vis; 2015; 21():515-22. PubMed ID: 25999678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14.
    Sishtla K; Pitt N; Shadmand M; O'Hare MN; Sulaiman RS; Sinn AL; Condon K; Pollok KE; Sandusky GE; Corson TW
    Sci Rep; 2018 Nov; 8(1):16152. PubMed ID: 30385851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model.
    Allaman-Pillet N; Oberson A; Schorderet DF
    Oncotarget; 2017 Feb; 8(9):15490-15506. PubMed ID: 28099942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-340 Exerts Suppressive Effect on Retinoblastoma Progression by Targeting KIF14.
    Xu HK; Wang XD; Wang DG; Wei DD; Liang L; Liu CH
    Curr Eye Res; 2021 Feb; 46(2):232-238. PubMed ID: 32757684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIF14 as an oncogene in retinoblastoma: a target for novel therapeutics?
    Basavarajappa HD; Corson TW
    Future Med Chem; 2012 Nov; 4(17):2149-52. PubMed ID: 23190103
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression analysis of 6p22 genomic gain in retinoblastoma.
    Orlic M; Spencer CE; Wang L; Gallie BL
    Genes Chromosomes Cancer; 2006 Jan; 45(1):72-82. PubMed ID: 16180235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.
    Landreville S; Ma D; Wu J; Harbour JW
    Curr Eye Res; 2010 May; 35(5):435-9. PubMed ID: 20450257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1.
    Bowles E; Corson TW; Bayani J; Squire JA; Wong N; Lai PB; Gallie BL
    Genes Chromosomes Cancer; 2007 Feb; 46(2):118-29. PubMed ID: 17099872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
    Thériault BL; Pajovic S; Bernardini MQ; Shaw PA; Gallie BL
    Int J Cancer; 2012 Apr; 130(8):1844-54. PubMed ID: 21618518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers.
    Corson TW; Huang A; Tsao MS; Gallie BL
    Oncogene; 2005 Jul; 24(30):4741-53. PubMed ID: 15897902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of p75 neurotrophin receptor expression accompanies malignant progression to human and murine retinoblastoma.
    Dimaras H; Coburn B; Pajovic S; Gallie BL
    Mol Carcinog; 2006 May; 45(5):333-43. PubMed ID: 16555252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
    Pappas L; Xu XL; Abramson DH; Jhanwar SC
    Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors.
    Singh HP; Wang S; Stachelek K; Lee S; Reid MW; Thornton ME; Craft CM; Grubbs BH; Cobrinik D
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9391-E9400. PubMed ID: 30213853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple genetic loci modify risk for retinoblastoma in transgenic mice.
    Griep AE; Krawcek J; Lee D; Liem A; Albert DM; Carabeo R; Drinkwater N; McCall M; Sattler C; Lasudry JG; Lambert PF
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2723-32. PubMed ID: 9856783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p75 NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development.
    Dimaras H; Gallie BL
    Int J Cancer; 2008 May; 122(9):2023-9. PubMed ID: 18196575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer.
    Wang ZZ; Yang J; Jiang BH; Di JB; Gao P; Peng L; Su XQ
    Int J Oncol; 2018 Nov; 53(5):1939-1952. PubMed ID: 30226594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.